Trademark: 97644561
Word
ALMEE
Status
Pending
Status Code
686
Status Date
Tuesday, March 12, 2024
Serial Number
97644561
Mark Type
3000
Filing Date
Monday, October 24, 2022
Published for Opposition
Tuesday, March 12, 2024

Trademark Owner History
Vicore Pharma AB - Owner At Publication

Classifications
41 Providing of on-line training and continuing education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; Educational services, namely, providing continuing professional education courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from depression and anxiety related to Pulmonary Fibrosis and for medical personnel specialized on the treatment of depression and anxiety
9 Downloadable computer software with medical information and content for facilitating the provision of medical advice in the field of depression and anxiety related to Pulmonary Fibrosis; downloadable computer software programs for the administration of scientific content in the nature of analysis of medical data; downloadable computer programs, in particular interactive downloadable medical software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis and for supporting medical personnel for the purpose of treating depression and anxiety; downloadable computer software program which is designed to assist patients in reducing and coping with the symptoms of depression and anxiety related to Pulmonary Fibrosis as well as in improving their wellbeing and social occupational functioning and to support health care professionals involved in the treatment of patients with depression and anxiety related to Pulmonary Fibrosis by facilitating the provision of medical advice; downloadable computer application software for websites, mobile telephones and mobile devices, namely, software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; downloadable printable educational materials featuring therapeutic medical and counselling content, in the nature of information, forms, instructions, charts, studies, data and related coaching and advice in the field of depression and anxiety related to Pulmonary Fibrosis, treatment of depression and anxiety related to Pulmonary Fibrosis, and related health and wellness; downloadable electronic publications, namely, newsletters and articles for use by medical professionals and patients in the field of depression and anxiety related to Pulmonary Fibrosis
44 Therapeutic services, namely, medical counselling, psychological counselling, medical advice and medical information provided to patients with, and care givers treating, depression and anxiety related to Pulmonary Fibrosis; Providing medical information, namely, computer-based interactive medical support services in the nature of providing online medical advice for assisting with treatment of patients suffering from depression and anxiety related to Pulmonary Fibrosis and their families
42 Providing a website featuring digital therapeutic technology that enables users to access resources for treating depression and anxiety related to Pulmonary Fibrosis; providing an online digital therapeutic platform in the nature of providing on-line non-downloadable software for providing behavioural health services, namely, coaching, counselling, advice in the field of depression and anxiety related to Pulmonary Fibrosis; conducting medical and scientific and technological research in the field of depression and anxiety related to Pulmonary Fibrosis; Scientific and technological services, namely, conducting technological research and design of digital therapeutics for computer-based interactive and online psychological intervention and counselling in the field of depression and anxiety related to Pulmonary Fibrosis; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of depression and anxiety related to Pulmonary Fibrosis and the treatment of depression and anxiety related to Pulmonary Fibrosis
The mark consists of of a green outline of overlapping, rounded geometric figures all connected at the bottom above "ALMEE" in stylized green font. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
The color(s) green is/are claimed as a feature of the mark.

Trademark Events
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 1, 2024
Electronic Record Review Complete
Jan 19, 2024
On Hold - Electronic Record Review Required
Jan 17, 2024
Approved For Pub - Principal Register
Dec 7, 2023
Teas/Email Correspondence Entered
Dec 6, 2023
Correspondence Received In Law Office
Dec 6, 2023
Teas Response To Office Action Received
Sep 14, 2023
Notification Of Non-Final Action E-Mailed
Sep 14, 2023
Non-Final Action E-Mailed
Sep 14, 2023
Non-Final Action Written
Sep 13, 2023
Teas/Email Correspondence Entered
Sep 13, 2023
Correspondence Received In Law Office
Sep 7, 2023
Notification Of Non-Final Action E-Mailed
Sep 7, 2023
Non-Final Action E-Mailed
Sep 7, 2023
Non-Final Action Written
Aug 18, 2023
Suspension Checked - To Attorney For Action
Jun 28, 2023
Teas Response To Suspension Inquiry Received
Feb 1, 2023
Notification Of Letter Of Suspension E-Mailed
Feb 1, 2023
Letter Of Suspension E-Mailed
Feb 1, 2023
Suspension Letter Written
Jan 26, 2023
Teas/Email Correspondence Entered
Jan 25, 2023
Correspondence Received In Law Office
Jan 25, 2023
Teas Response To Office Action Received
Jan 19, 2023
Notification Of Non-Final Action E-Mailed
Jan 19, 2023
Non-Final Action E-Mailed
Jan 19, 2023
Non-Final Action Written
Jan 19, 2023
Assigned To Examiner
Nov 8, 2022
Notice Of Design Search Code E-Mailed
Nov 7, 2022
New Application Office Supplied Data Entered
Oct 27, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24